M. Docteur MAXIME ABOUDIAB

Bibliographie

• Interest in daily clinical practice of screening for gouty disease in patients with psoriatic arthritis

  2024

  ArticleRheumatology Advances in Practice

Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).

Localisation

Adresses géocodées via la Base Adresse Nationale (api-adresse.data.gouv.fr). Précision indicative.

Lieux de consultation

• CABINET DU DR MAXIME ABOUDIAB

  40 AVENUE LEON BLUM, 60000 Beauvais

  Libéral
  © OpenStreetMap

  📷 Street View ↗🗺️ Maps ↗OSM ↗

• CH BEAUVAIS

  40 Avenue LÉON BLUM, 60021 Beauvais

  ☎ 0344112121Hospitalier🏥 Centre CH ↗

Tarifs & secteur de conventionnement

Prendre rendez-vous & contact

Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).

Top publications · les plus citées

• 1

  Vertebral fracture assessment (VFA) in patients over 50 years of age with a non-severe peripheral fracture

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2020

  📚 9 citations🩺 Clinique
• 2

  Interest in daily clinical practice of screening for gouty disease in patients with psoriatic arthritis

  Rheumatology advances in practice · 2024

  📚 1 citations🔓 Open Access📄 PDF gratuit ↗

  Lire l'abstract Crossref ↓

  Abstract Objectives PsA and gout are two prevalent rheumatic diseases, that can be associated as part of a rheumatism known as ‘Psout’. Both conditions are associated with cardiovascular (CV) risk, thus their co-occurrence could have significant implications for the management of CV risks and patient care. This study aimed to determine the prevalence of gout within a PsA patient cohort and, consequently, to identify factors associated with this pathological association. Methods This is an observational, descriptive, cross-sectional, single-center study, including patients diagnosed with PsA. Demographic, clinical, biological and imaging data were collected. We identified the proportion of patients simultaneously affected by PsA and gout and compared characteristics between those with and without gout. Results The prevalence of gout among PSA patients was 9.8% (12/122), with a prevalence of 23% for asymptomatic hyperuricemia and 7.4% presenting with specific US signs of gout. Significant associated factors in the univariate analysis included weight, hypertension, diabetes, certain medications (diuretics, aspirin, lipid-lowering agents), impaired renal function, elevated fasting blood glucose, lipid abnormalities and specific US signs of gout. Conclusion Our study has described the existence of patients simultaneously affected by PsA and gout (‘Psout’). Performing joint US along with uric acid level measurements in PsA patients can enable personalized therapeutic care.

Publications scientifiques (4) — classées par pathologie

Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).

Partager cette fiche